Recurrent Melanoma Completed Phase 2 Trials for Ixabepilone (DB04845)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00036764BMS-247550 in Treating Patients With Stage IV MelanomaTreatment